MediciNova Inc expected to post a loss of 14 cents a share - Earnings Preview

Medicinova

06/05/2025 08:18

MediciNova Inc MNOV.OQ MNOV.O is expected to show no change in quarterly revenue when it reports  results on May 8 (estimated) for the period ending March 31 2025

​LSEG's mean analyst estimate for MediciNova Inc is for a loss of 14 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for MediciNova Inc is $7.50​, above​ its last closing price of $1.50. ​​​

This summary was machine generated May 6 at 07:18 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)